X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1305) 1305
science & technology (1305) 1305
life sciences & biomedicine (1296) 1296
female (757) 757
administration, cutaneous (751) 751
male (699) 699
dermatology (538) 538
adult (489) 489
middle aged (481) 481
aged (326) 326
treatment outcome (301) 301
pharmacology & pharmacy (280) 280
animals (254) 254
skin (233) 233
adolescent (216) 216
care and treatment (191) 191
allergy (169) 169
immunology (146) 146
young adult (145) 145
child (143) 143
drug therapy (136) 136
aged, 80 and over (129) 129
research (118) 118
complications and side effects (114) 114
drug eruptions - etiology (113) 113
health aspects (107) 107
medicine & public health (107) 107
double-blind method (106) 106
drugs (106) 106
abridged index medicus (99) 99
drug-related side effects and adverse reactions (97) 97
analysis (95) 95
toxic epidermal necrolysis (94) 94
risk factors (93) 93
general & internal medicine (90) 90
patients (89) 89
administration, oral (88) 88
skin - drug effects (85) 85
transdermal medication (84) 84
medicine, general & internal (83) 83
prospective studies (83) 83
skin - pathology (82) 82
diagnosis (80) 80
retrospective studies (80) 80
side effects (80) 80
child, preschool (77) 77
cutaneous adverse drug reactions (77) 77
stevens-johnson syndrome (76) 76
diagnosis, differential (72) 72
dose-response relationship, drug (69) 69
severe cutaneous adverse reactions (69) 69
clinical trials (68) 68
oncology (68) 68
drug eruptions - diagnosis (64) 64
pharmacology/toxicology (64) 64
severity of illness index (64) 64
time factors (62) 62
skin absorption (61) 61
cancer (60) 60
dosage and administration (60) 60
usage (60) 60
drug therapy, combination (59) 59
follow-up studies (58) 58
drug delivery systems (57) 57
infectious diseases (56) 56
skin - metabolism (54) 54
skin diseases (54) 54
drug administration schedule (53) 53
infant (53) 53
hypersensitivity (51) 51
internal medicine (51) 51
leishmaniasis, cutaneous - drug therapy (51) 51
medical research (51) 51
mice (50) 50
pediatrics (50) 50
medicine (49) 49
vasculitis, leukocytoclastic, cutaneous - chemically induced (49) 49
cutaneous (48) 48
toxicology (48) 48
case report (47) 47
immunotherapy (47) 47
pain (47) 47
rats (47) 47
cutaneous leishmaniasis (46) 46
patch tests (46) 46
treatment (46) 46
dermatitis (45) 45
dermatologic agents - administration & dosage (45) 45
psoriasis (45) 45
studies (45) 45
rheumatology (44) 44
safety (44) 44
anticonvulsants - adverse effects (43) 43
neurosciences & neurology (43) 43
pharmacology (43) 43
pharmacotherapy (43) 43
antineoplastic agents - adverse effects (42) 42
anti-inflammatory agents, non-steroidal - adverse effects (41) 41
drug eruptions - pathology (41) 41
leishmaniasis (41) 41
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1822) 1822
French (21) 21
Japanese (17) 17
Spanish (11) 11
Portuguese (10) 10
Korean (9) 9
German (8) 8
Italian (4) 4
Dutch (3) 3
Russian (3) 3
Chinese (2) 2
Polish (2) 2
Danish (1) 1
Norwegian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2014, Volume 135, Issue 3, pp. 745 - 752.e5
Journal Article
Dermatologic clinics, ISSN 0733-8635, 10/2019, Volume 37, Issue 4, p. 555
Journal Article
Journal of human genetics, ISSN 1434-5161, 06/2013, Volume 58, Issue 6, pp. 317 - 326
.... However, in this decade, genetic markers have been found for several ADRs, especially for severe cutaneous adverse reactions (SCARs... 
drug-induced liver injury | pharmacogenomics | severe cutaneous adverse reactions | human leukocyte antigen | genome-wide association study | Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | HLA-DQ alpha-Chains - immunology | Stevens-Johnson Syndrome - immunology | Benzylamines - adverse effects | Humans | HLA Antigens - genetics | HLA-DQ alpha-Chains - genetics | Drug Hypersensitivity - genetics | Ticlopidine - adverse effects | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Dideoxynucleosides - adverse effects | HLA-B Antigens - genetics | Skin - pathology | Skin - immunology | Pharmacogenetics | Diclofenac - analogs & derivatives | Diclofenac - adverse effects | Azetidines - adverse effects | HLA-B Antigens - immunology | HLA Antigens - immunology | Chemical and Drug Induced Liver Injury - genetics | Floxacillin - adverse effects | Genetic Markers | Chemical and Drug Induced Liver Injury - immunology | Drug Hypersensitivity - pathology | HLA-A Antigens - immunology | Stevens-Johnson Syndrome - genetics | Carbamazepine - adverse effects | Drug Hypersensitivity - immunology | Alleles | Allopurinol - adverse effects | HLA-A Antigens - genetics | Quinazolines - adverse effects | Skin - drug effects | Flucloxacillin | Risk groups | DQA1 protein | Allopurinol | Hypersensitivity | Liver | Drug development | Carbamazepine | Genetic screening | Ticlopidine | Quality of life | Side effects | Genetic markers | Abacavir | Histocompatibility antigen HLA | Index Medicus
Journal Article
The Journal of clinical investigation, ISSN 1558-8238, 02/2018, Volume 128, Issue 3, pp. 985 - 996
Journal Article
Indian Journal of Dermatology, ISSN 0019-5154, 3/2019, Volume 64, Issue 2, pp. 122 - 128
Journal Article